CIN-110

N/A

Report date: 2024/04/01 16:13:30

Base Information

Drug NameCIN-110
Drug Alias NameCIN-110JNJ-9321
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionNeuropeptide Y receptor type 2 agonists
TargetsNeuropeptide Y receptor type 2
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Sciences Ireland Unlimited Company
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Sciences Ireland Unlimited CompanyCinFina Pharma LLC
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A